On Friday Boston-based Pear Therapeutics announced a whopping $64 million Series C funding. The latest financing was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, ...
Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer Biomet. "We plan on providing financial guidance for fiscal year 2026 once we ...
This review is led by Professor Kongming Wu (State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results